ѻý

Clinical Challenges: Test Your Knowledge on Cancer and Immunotherapy

<ѻý class="mpt-content-deck">— A three-question quiz on neoadjuvant immunotherapy, cancer vaccines, NSCLC with driver mutations
MedpageToday
A blue and pink neon sign with the words QUIZ TIME

A ѻý Clinical Challenges series discussed three areas of cancer immunotherapy: neoadjuvant immunotherapy, cancer vaccines, and immunotherapy for non-small cell lung cancer (NSCLC) with driver mutations.

This three-question quiz will test your knowledge on one aspect of each of the articles in this series. Correct answers and explanations appear after completing the quiz.

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined ѻý in 2007.